The role of compression therapy after endovenous laser ablation (EVLA)

The role of compression therapy after endovenous laser ablation (EVLA) – review

Published:2023-11-27 Issue:SUPLEMENT 1 Volume:96 Page:109-113
ISSN:0032-373X
Container-title:Polish Journal of Surgery
language:
Short-container-title:Pol Przegl Chir

Author:

Świątek Łukasz¹^ORCID,Stępak Hubert²^ORCID,Krasiński Zbigniew²^ORCID

Affiliation:

1. Student’s Scientific Section of Vascular Surgery, Poznan University of Medical Sciences, Poland

2. 2 Department of Vascular and Endovascular Surgery, Angiology and Phlebology, Poznan University of Medical Sciences, University Hospital of Lord’s Transfiguration, Poznan, Poland

Abstract

Introduction: Chronic venous disease (CVD) is a rising problem in western countries. There are several stages of CVD that can be treated with different ways. One of the methods of treating varicosity, C2 stage of CVD, is still developing endovenous laser ablation (EVLA). This method is popular due to its short operation time, less bleeding, quick recovery and no surgical scars. The compression therapy in form of compression stockings has been widely used as a conservative treatment of early stage CVD and it's also used after EVLA. However there are no strong recommendations towards using compression therapy after this kind of surgery. Aim and Method: This paper is aimed to review existing knowledge about compression therapy benefits and its recommended time period after EVLA. Search engines used in review: Pubmed and Cochrane. Results: Studies focusing on the compression therapy after EVLA of varicose veins have questioned the prolonged use of compression therapy as it brings no additional benefits and might be difficult for patients to adhere. The existing studies recommended the time period no greater than 1-2 weeks. There are no significant changes in reoccurrence rate and return to normal activities between compression and non-compression group. It is proven that compression therapy significantly reduces the postoperative pain and consumption of analgesics. Discussion: Compression therapy seems as a safe option for low pain management. There is a need for further research involving the impact of the compression therapy after EVLA, especially in group of low energy delivered settings as the results of treatment are promising.

Publisher

Index Copernicus

Link

https://ppch.pl/gicid/pdf/01.3001.0053.9855

Reference30 articles.

1. Davies A.H.: The Seriousness of Chronic Venous Disease: A Review of Real--World Evidence. Adv Ther., 2019; 36: 5–12. https://doi.org/10.1007/s12325-019-0881-7.

2. Lurie F., Passman M., Meisner M. et al.: The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord.,2020; 8: 342–352. https://doi.org/10.1016/J.JVSV.2019.12.075.

3. Mansilha A., Sousa J.: Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy. Int J Mol Sci., 2018; 19: 1669 https://doi.org/10.3390/ijms19061669.

4. DePopas Matthew E.B.: Varicose Veins and Lower Extremity Venous Insufficiency. Semin Intervent Radiol., 2018; 35: 56–61. https://doi.org/10.1055/s-0038-1636522.

5. Wittens C., Davies A.H., Bækgaard N. et al.: Editor’s Choice – Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg., 2015;49: 678–737. https://doi.org/10.1016/j.ejvs.2015.02.007.